Search
Sysmex South Africa
South Africa | EN
Company
Company
Back
Company
Who is Sysmex?
Who is Sysmex?
Back
Sustainability
Sustainability
Back
News & Events
News & Events
Back
Career
Career
Back
Contacts
Contacts
Back
Products
Products
Back
Products
Diagnostics
Diagnostics
Back
Life Science
Life Science
Back
Solution Provision
Solution Provision
Back
Services
Services
Back
Services
Consulting
Consulting
Back
Service contacts
Service contacts
Back
QC & Online Services
QC & Online Services
Back
Document Centre
Document Centre
Back
Academy
Academy
Back
Academy
Knowledge Centre
Knowledge Centre
Back
Clinic & Laboratory
Clinic & Laboratory
Back
Training
Training
Back
Library
Library
Back
Menu
Headquarters
Sysmex Group Companies
Select your local website
Sysmex South Africa Academy Library Documents

Scientific documents library

Filter results by document type and/or working area to find what you're searching for.

Filter
  • White Paper
  • Haematology
White Paper: The value of the immature platelet count for managing immune thrombocytopenia (ITP) treatment and assessing the risk of bleeding

The treatment of immune thrombocytopenia (ITP) can be challenging. The immature platelet count (IPF) can be used in ITP as a supportive information to assess whether the treatment mechanism is having an effect: To have a supportive parameter to answer the clinical question as to whether the observed increase in the platelet count is due to increased platelet production or inhibition of antibody-mediated platelet destruction. Due to the higher reactivity and haemostatic potential of immature platelets, an increased immature platelet count was also found to be associated with a lower risk of bleeding with severely thrombocytopenic patients.

Details Download
  1. 1
  2. 2
  3. 3
  4. 4
Sysmex South Africa (Pty) Ltd
Fernridge Office Park, Block 1,
Randburg 2194
+27 (11) 329 94 80
info@sysmex.co.za
Service
Social Media
Copyright © Sysmex Europe SE. All rights reserved.